VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $894,282 | -65.1% | 95,441 | -8.6% | 0.00% | -75.0% |
Q2 2023 | $2,562,453 | +20.6% | 104,462 | +14.4% | 0.00% | +33.3% |
Q1 2023 | $2,124,504 | -9.2% | 91,298 | -1.2% | 0.00% | -25.0% |
Q4 2022 | $2,339,403 | +32.9% | 92,430 | +1.3% | 0.00% | +33.3% |
Q3 2022 | $1,760,000 | -25.5% | 91,284 | -1.5% | 0.00% | -25.0% |
Q2 2022 | $2,361,000 | +13.1% | 92,706 | +14.2% | 0.00% | +33.3% |
Q1 2022 | $2,088,000 | -43.2% | 81,171 | -7.6% | 0.00% | -25.0% |
Q4 2021 | $3,679,000 | -1.4% | 87,865 | +2.5% | 0.00% | -20.0% |
Q3 2021 | $3,730,000 | -4.8% | 85,697 | +3.4% | 0.01% | 0.0% |
Q2 2021 | $3,917,000 | -5.4% | 82,852 | +2.5% | 0.01% | 0.0% |
Q1 2021 | $4,142,000 | +90.4% | 80,792 | -0.5% | 0.01% | +66.7% |
Q4 2020 | $2,175,000 | -21.9% | 81,223 | +0.1% | 0.00% | -25.0% |
Q3 2020 | $2,786,000 | -2.6% | 81,141 | +16.2% | 0.00% | -20.0% |
Q2 2020 | $2,860,000 | +648.7% | 69,813 | +527.1% | 0.01% | +400.0% |
Q1 2020 | $382,000 | +176.8% | 11,133 | +1.2% | 0.00% | – |
Q4 2019 | $138,000 | – | 11,005 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |